|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 急性缺血性卒中的机械取栓治疗:ESO、ESMINT、ESNR和EAN共同支持的2014/2015 ESO-卡罗林斯卡卒中更新会议共识声明显示文摘这份卒中后机械取栓治疗共识声明的原始版本于2014年11月16—18日在斯德哥尔摩召开的欧洲卒中组织(European Stroke Organisation, ESO)-卡罗林斯卡卒中更新会议期间得到批准。根据会议安排,在2015年利用新的临床试验数据对该声明进行了更新。2015年2月,在瑞士伯尔尼召开的ESO冬季培训会期间组织了面对面会议对共识声明进行修订,然后通过电子邮件交换意见,最终版本得到各学会的认可。推荐意见与原始版本一致,证据等级更新到2015年2月20日为止,在2015年5月15日获得确认。ESO-卡罗林斯卡卒中更新会议的目的在于总结卒中治疗研究的最新进展并探讨如何将这些最新研究结果应用于临床实践。共识会议选择了一些议题进行讨论,与会者草拟一份共识声明并进行讨论。该声明接受了ESO指南委员会的指导。这份共识声明包括对急性卒中后机械取栓治疗的推荐意见,得到欧洲卒中组织ESO、欧洲神经微创治疗学会(European Society of Minimally Invasive Neurological Therapy, ESMINT)、欧洲神经放射学学会(European Society of Neuroradiology, ESNR)和欧洲神经病学学会(European Academy of Neurology, EAN)的支持。 | Nils Wahlgren Tiago Moreira Patrik Michel Thorsten Steiner Olav Jansen Christophe Cognard Heinrich P Mattle Wim van Zwam Staffan Holmin Turgut Tatlisumak Jesper Petersson Valeria Caso Werner Hacke Mikael Mazighi Marcel Arnold Urs Fischer Istvan Szikora Laurent Pierot Jens Fiehler Jan Gralla Franz Fazekas Kennedy R Lees 高洁 徐格林 | 2016 | 国际脑血管病杂志2016，24，1： | 5 |
| 2 | Yeast and mammalian metallothioneins functionally substitute for yeast copper - zinc superoxide dismutase 显示文摘 | Tamai KT Gralla EB Ellerby LM | 1993 | Proc Natl Acad Sci USA1993，90，： | 2 |
| 3 | 卒中介入治疗培训指南:国际多学会共识文件显示文摘1背景
缺血性卒中是全球人口死亡和残疾的首要原因。很多急性大血管闭塞(emergent large vesselocclusion,ELVO)患者都会遗留长期残疾。事实上,这些颅内大动脉闭塞经常会导致大面积脑损伤,进而造成患者死亡或严重致残。 | Lavine SD Cockroft K Hoh B Bambakidis N Khalessi AA Woo H Riina H Siddiqui A Hirsch JA Chong W Rice H Wenderoth J Mitchell P Coulthard A Signh TJ Phatorous C Khangure M Klurfan P ter Brugge K Iancu D Gunnarsson T Pongpech S Rodesch G Soderman M Taylor A Krings T Orbach D Picard L Suh DC Zheng HQ Jansen O Muto M Szikora I Pierot L Brouwer P Gralla J Renowden S Andersson T Fiehler J Turjman F White P Januel AC Spelle L Kulcsar Z Chapot R Biondi A Dima S Taschner C Szajner M Krajina A Sakai N Matsumaru Y Yoshknura S Ezura M Fujinaka T Iihara K Ishii A Higashi T Hirohata M Hyodo A Ito Y Kawanishi M Kiyosue H Kobayashi E Kobayashi S Kuwayama N Matsumoto Y Miyachi S Murayama Y Nagata I Nakahara I Nemoto S Niimi Y Oishi H Satomi J Satow T Sugiu K Tanaka M Terada T Yamagami H Diaz O Lylyk P Jayaraman MV Patsalides A Gandhi CD Lee SK Abruzzo T Albani B Ansari SA Arthur AS Baxter BW Bulsara KR Chen M Almandoz JE Fraser JF Heck DV Hetts SW Hussain MS Klucznik RP Leslie-Mawzi TM Mack WJ McTaggart RA Meyers PM Mocco J Prestigiacomo CA Pride GL Rasmussen PA Starke RM Sunenshine PJ Tarr RW Frei DF Pabo M Nogueira RG Zaidat OO Jovin T Linfante I Yavagal D Liebeskind D Novakovic R Pongpech S 许岩 孙瑞 郭芮兵 | 2017 | 国际脑血管病杂志2017，25，5： | 2 |
| 4 | Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation显示文摘 | Scott W. Biggins James Trotter Jane Gralla James R. Burton Kiran M. Bambha Jennifer Dodge Megan Brocato Linling Cheng Matt McQueen Lisa Forman Michael Chang Igal Kam Gregory Everson Richard A. Spritz Goran Klintmalm Hugo R. Rosen | 2013 | Journal of Hepatology2013，，5： | 2 |
| 5 | Neuronavigation:concept,techniques and applications显示文摘 | Ganslandt O Behari S Gralla J | 2002 | Neurol India2002，50，3： | 1 |
| 6 | Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy:results of a double-blind randomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron 显示文摘 | Gralla R lichinitser M Van Der Vegt S | 2003 | Ann Oncol2003，14，10： | 1 |
| 7 | Assessing and managing venous irritation associated with vinorelbins tartrate 显示文摘 | Rittenberg CN Gralla RJ Rehmeyer T A | 1995 | Oncol Nurs Forum1995，22，4： | 1 |
| 8 | Management of transient ischemic attack (tia) and acute stroke 显示文摘 | Heldner MR Arnold M Gralla J | 2012 | Praxis ( Bern 1994 )2012，101，6： | 1 |
| 9 | Poising of Escherichiacoli RNA polymerase and its release from the sigma 38C-terminal tail for osmY transcription显示文摘 | Rosenthal AZ Kim Y Gralla JD | 2008 | J Mol Biol2008，376，4： | 1 |
| 10 | Antiemetic efficacy of the neurokinin-1antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid inpatients receiving anthracyclines or cyclophosphamide in addition to highdosecisplatin: analysis of combineddata from two Phase III randomizedclinical trials显示文摘 | Gralla RJ1 de Wit R Herrstedt J | 2005 | Cancer2005，104，4： | 1 |
| 11 | Toxicity studies with ethyl mahol显示文摘 | Stebbins R B Coleman G L | 1969 | Toxicology and Applied Pharmacology1969，15，3： | 1 |
| 12 | Tissue engineering:Creation of long-lasting blood vessels显示文摘 | Koike N Fukumura D Gralla O | 2004 | Nature2004，428，： | 1 |
| 13 | Image-guided removal of supratentorial cavemomas in critical brain areas: application of neuronavigation and intraoperative magnetic resonance imaging显示文摘 | Gralla J Ganslandt O Kober H | 2003 | Minim lnvasive Neurosurg2003，46，2： | 1 |
| 14 | Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy显示文摘 | Warr DG Hesketh PJ Gralla RJ | | 0，，12： | 1 |
| 15 | Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection显示文摘 | Huskey J Gralla J Wiseman AC | 2011 | Clin J Am Soc Nephrol2011，6，2： | 1 |
| 16 | Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase 显示文摘 | Tamai KT Gralla EB Ellerby LM | 1993 | Proc Natl Acad Sci USA1993，90，： | 1 |
| 17 | Efficacy and tolerability of aprepitant for prevention of chemotherapy induced nausea and vomiting in patient with breast cancer after moderately emetogenic chemotherapy显示文摘 | Wart DG Hesketh PJ Gralla RJ | 2005 | J Clin Oncol2005，23，12： | 1 |
| 18 | Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron显示文摘 | Gralla R Lichinitser M Van Der Vegt S | 2003 | Ann Oncol2003，14，10： | 1 |
| 19 | Complications of pediatric femur fractures treated with titanium elastic nails= a comparison of fracture types显示文摘 | Sink EL Gralla J Repine M | 2005 | J Pediatr Orthop2005，25，5： | 1 |
| 20 | The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational,randomized,double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-- the Aprepitant Protocol 052 Study Group 显示文摘 | Hesketh PJ Grunberg SM Gralla RJ | 2003 | J Clin Oncol2003，21，22： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员